Tech Company Financing Transactions
Napo Pharmaceuticals Funding Round
Napo Pharmaceuticals, based in San Francisco, received $3 million from private investors.
Transaction Overview
Company Name
Announced On
6/22/2011
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$2,996,869
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Amount includes common stock and promissory notes convertible into common stock. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
201 Mission St. 2375
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Website
Email Address
Overview
Napo Pharmaceuticals focuses on the development and commercialization of proprietary pharmaceuticals for the global marketplace in collaboration with local partners. It is currently developing a proprietary gastro-intestinal compound in clinical development for four distinct product indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lisa Conte
Chief Financial Officer
Karen Wright
Executive Vice President
Steven King
Vice President
David Upchurch
VP - Bus. Development
Katie MacFarlane
VP - Manufacturing
David Sesin
VP - Marketing
Brian Zorn
VP - Sales
Peter Riojas
Browse more venture capital transactions:
Prev: 6/22/2011: Haiku Deck venture capital transaction
Next: 6/22/2011: Kyruus venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs